Eating Disorders

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MediLink Therapeutics
MediLink TherapeuticsChina - Suzhou
1 program
Enhanced Body-Swap for Anorexia NervosaN/A1 trial
Active Trials
NCT06799962RecruitingEst. Jan 2026

Trial Timeline

Clinical trial activity over time

2025
2026
MediLink TherapeuticsEnhanced Body-Swap for Anorexia Nervosa

Clinical Trials (1)

NCT06799962MediLink TherapeuticsEnhanced Body-Swap for Anorexia Nervosa

AI and VR Devices for Eating Behavior Rehabilitation

Start: Jan 2025Est. completion: Jan 2026
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space